- Home
- CRVS vs MIN Comparison
CRVS vs MIN Comparison
Compare CRVS & MIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- MIN
- Stock Information
- Founded
- CRVS 2014
- MIN 1988
- Country
- CRVS United States
- MIN United States
- Employees
- CRVS N/A
- MIN N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- MIN Trusts Except Educational Religious and Charitable
- Sector
- CRVS Health Care
- MIN Finance
- Exchange
- CRVS Nasdaq
- MIN Nasdaq
- Market Cap
- CRVS 305.4M
- MIN 302.7M
- IPO Year
- CRVS 2016
- MIN N/A
- Fundamental
- Price
- CRVS $5.75
- MIN $2.68
- Analyst Decision
- CRVS Strong Buy
- MIN
- Analyst Count
- CRVS 4
- MIN 0
- Target Price
- CRVS $15.00
- MIN N/A
- AVG Volume (30 Days)
- CRVS 518.7K
- MIN 331.0K
- Earning Date
- CRVS 08-07-2025
- MIN 01-01-0001
- Dividend Yield
- CRVS N/A
- MIN 7.31%
- EPS Growth
- CRVS N/A
- MIN N/A
- EPS
- CRVS N/A
- MIN 0.08
- Revenue
- CRVS N/A
- MIN N/A
- Revenue This Year
- CRVS N/A
- MIN N/A
- Revenue Next Year
- CRVS N/A
- MIN N/A
- P/E Ratio
- CRVS N/A
- MIN $33.38
- Revenue Growth
- CRVS N/A
- MIN N/A
- 52 Week Low
- CRVS $2.54
- MIN $2.52
- 52 Week High
- CRVS $10.00
- MIN $2.88
- Technical
- Relative Strength Index (RSI)
- CRVS 65.10
- MIN 49.09
- Support Level
- CRVS $5.28
- MIN $2.65
- Resistance Level
- CRVS $5.64
- MIN $2.71
- Average True Range (ATR)
- CRVS 0.30
- MIN 0.03
- MACD
- CRVS 0.03
- MIN -0.00
- Stochastic Oscillator
- CRVS 77.70
- MIN 41.67
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About MIN MFS Intermediate Income Trust
MFS Intermediate Income Trust is a diversified closed-end management investment company. The fund's investment objective is to seek high current income but may also consider capital appreciation. It invests the assets in debt instruments. Its portfolio of investments comprises of different sector investments such as the automotive, chemicals, energy, food and beverages, insurance, and other sectors.